• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Factor XII Deficiency Mimicking Bleeding Diathesis: A Unique Presentation and Diagnostic Pitfall.模仿出血素质的因子 XII 缺乏症:一种独特的表现及诊断陷阱。
Cureus. 2018 Jun 15;10(6):e2817. doi: 10.7759/cureus.2817.
2
Safety of Tonsillectomy and/or Adenoidectomy in Pediatric Patients with Prolonged Activated Partial Thromboplastin Time and Factor XII Deficiency.小儿活化部分凝血活酶时间延长和因子 XII 缺乏患者行扁桃体切除术和/或腺样体切除术的安全性
J Inflamm Res. 2024 May 31;17:3515-3525. doi: 10.2147/JIR.S462617. eCollection 2024.
3
[A patient with isolated prolongation of aPTT without hemorrhagic diathesis anamnesis: severe, hereditary factor XII deficiency].[一名活化部分凝血活酶时间(aPTT)单独延长且无出血素质既往史的患者:严重遗传性凝血因子Ⅻ缺乏症]
Ther Umsch. 1999 Sep;56(9):509-12. doi: 10.1024/0040-5930.56.9.509.
4
Factor XII (Hageman Factor) Deficiency: a rare harbinger of life threatening complications.凝血因子 XII(哈格曼因子)缺乏症:危及生命并发症的罕见先兆。
Pan Afr Med J. 2019 May 21;33:39. doi: 10.11604/pamj.2019.33.39.18117. eCollection 2019.
5
Influence of factor XII deficiency on activated partial thromboplastin time (aPTT) in critically ill patients.影响因子 XII 缺乏对危重症患者活化部分凝血活酶时间(aPTT)的影响。
J Thromb Thrombolysis. 2019 Oct;48(3):466-474. doi: 10.1007/s11239-019-01879-w.
6
Molecular genetic analysis of Korean patients with coagulation factor XII deficiency.韩国凝血因子XII缺乏症患者的分子遗传学分析。
Blood Coagul Fibrinolysis. 2010 Jun;21(4):308-12. doi: 10.1097/MBC.0b013e32833449df.
7
[Are we to pay attention to factor XII deficiency?].我们应该关注凝血因子 XII 缺乏症吗?
Vnitr Lek. 2015;61 Suppl 5:63-6.
8
The prevalence of moderate and severe FXII (Hageman factor) deficiency among the normal population: evaluation of the incidence of FXII deficiency among 300 healthy blood donors.正常人群中中重度凝血因子XII(哈格曼因子)缺乏症的患病率:对300名健康献血者中凝血因子XII缺乏症发病率的评估。
Thromb Haemost. 1994 Jan;71(1):68-72.
9
Hageman factor deficiency presentation and implications for management.哈格曼因子缺乏症的表现及管理意义。
Conn Med. 1992 Sep;56(9):469-71.
10
[Are we to pay attention to factor XII deficiency?].[我们应该关注凝血因子 XII 缺乏症吗?]
Vnitr Lek. 2015 Dec;61(12 Suppl 5):5S63-6.

引用本文的文献

1
Genetic analysis of a pedigree with hereditary coagulation factor XII deficiency.遗传性凝血因子XII缺乏症家系的基因分析
Ann Hematol. 2025 Feb;104(2):1281-1289. doi: 10.1007/s00277-025-06205-4. Epub 2025 Jan 22.
2
Long-term safety and efficacy of garadacimab for preventing hereditary angioedema attacks: Phase 3 open-label extension study.加拉达昔单抗预防遗传性血管性水肿发作的长期安全性和有效性:3期开放标签扩展研究。
Allergy. 2025 Feb;80(2):545-556. doi: 10.1111/all.16351. Epub 2024 Oct 7.
3
Factor XI Inhibition for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Undergoing Central Line Placement: A Phase 2 Clinical Trial.XI 因子抑制预防癌症患者中心静脉置管相关血栓形成的:一项 2 期临床试验。
Arterioscler Thromb Vasc Biol. 2024 Jan;44(1):290-299. doi: 10.1161/ATVBAHA.123.319692. Epub 2023 Nov 16.
4
Noonan syndrome with RAF1 gene mutations in a newborn with cerebral haemorrhage.新生儿脑出血合并 RAF1 基因突变的努南综合征。
Eur J Med Res. 2022 Aug 11;27(1):146. doi: 10.1186/s40001-022-00772-2.
5
Factor XII deficiency in asymptomatic Saudi population: A retrospective cohort study.沙特无症状人群中的因子 XII 缺乏症:一项回顾性队列研究。
Saudi J Biol Sci. 2021 Mar;28(3):2004-2006. doi: 10.1016/j.sjbs.2021.01.002. Epub 2021 Jan 8.

本文引用的文献

1
Hereditary angioedema with normal C1 inhibitor: Four types and counting.C1抑制剂正常的遗传性血管性水肿:已有四种类型且仍在增加。
J Allergy Clin Immunol. 2018 Mar;141(3):884-885. doi: 10.1016/j.jaci.2018.01.015. Epub 2018 Feb 2.
2
In vivo roles of factor XII.体内因子 XII 的作用。
Blood. 2012 Nov 22;120(22):4296-303. doi: 10.1182/blood-2012-07-292094. Epub 2012 Sep 19.
3
Aspirin for preventing the recurrence of venous thromboembolism.阿司匹林预防静脉血栓栓塞复发。
N Engl J Med. 2012 May 24;366(21):1959-67. doi: 10.1056/NEJMoa1114238.
4
Prolonged versus standard-duration venous thromboprophylaxis in major orthopedic surgery: a systematic review.大骨科手术后延长与标准疗程静脉血栓预防的系统评价。
Ann Intern Med. 2012 May 15;156(10):720-7. doi: 10.7326/0003-4819-156-10-201205150-00423. Epub 2012 Mar 12.
5
Hageman factor, platelets and polyphosphates: early history and recent connection. Hageman 因子、血小板和多聚磷酸盐:早期历史与近期关联。
J Thromb Haemost. 2010 Aug;8(8):1670-4. doi: 10.1111/j.1538-7836.2010.03893.x. Epub 2010 Apr 30.
6
Clinical practice. Hereditary angioedema.临床实践。遗传性血管性水肿。
N Engl J Med. 2008 Sep 4;359(10):1027-36. doi: 10.1056/NEJMcp0803977.
7
How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults.如何解读及追查成人的凝血酶原时间、活化部分凝血活酶时间及出血时间异常情况。
Mayo Clin Proc. 2007 Jul;82(7):864-73. doi: 10.4065/82.7.864.
8
A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma.一种与血浆中促凝成分缺乏相关的家族性出血性状。
J Clin Invest. 1955 Apr;34(4):602-13. doi: 10.1172/JCI103109.
9
Defective intrinsic fibrinolytic activity in a patient with severe factor XII-deficiency and myocardial infarction.一名严重缺乏凝血因子XII且患有心肌梗死的患者存在内源性纤维蛋白溶解活性缺陷。
Scand J Haematol. 1984 Jul;33(1):80-2. doi: 10.1111/j.1600-0609.1984.tb02214.x.
10
Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: a report of 21 patients and a review of 50 previously reported cases.先天性凝血因子异常和慢性血小板减少症中的血栓形成或心肌梗死:21例报告及对50例既往报道病例的综述
Medicine (Baltimore). 1983 Jul;62(4):248-55. doi: 10.1097/00005792-198307000-00004.

模仿出血素质的因子 XII 缺乏症:一种独特的表现及诊断陷阱。

Factor XII Deficiency Mimicking Bleeding Diathesis: A Unique Presentation and Diagnostic Pitfall.

作者信息

Fernandes Hermina D, Newton Shauna, Rodrigues Jonathan M

机构信息

Internal Medicine, University of North Dakota School of Medicine and Health Sciences, Bismarck, USA.

出版信息

Cureus. 2018 Jun 15;10(6):e2817. doi: 10.7759/cureus.2817.

DOI:10.7759/cureus.2817
PMID:30128221
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6093754/
Abstract

Factor XII (FXII), also known as Hageman factor, is a coagulation protein that is necessary for the functioning of the intrinsic coagulation cascade and fibrin formation. When deficient, it results in a significant prolongation of activated partial thromboplastin time (aPTT), mimicking a bleeding disorder. However, it does not result in clinical bleeding tendency. We report a case of an elderly male who was found to have prolonged aPTT, discovered during preoperative evaluation for operative repair of hip fracture. Although laboratory investigation was suggestive of bleeding tendency, he was diagnosed with factor XII deficiency and had no bleeding complications intra-operatively or in the post-operative period.

摘要

凝血因子 XII(FXII),也称为哈格曼因子,是一种凝血蛋白,对于内源性凝血级联反应和纤维蛋白形成的功能是必需的。当缺乏时,它会导致活化部分凝血活酶时间(aPTT)显著延长,类似于出血性疾病。然而,它不会导致临床出血倾向。我们报告一例老年男性病例,该患者在因髋部骨折手术修复进行术前评估时发现 aPTT 延长。尽管实验室检查提示有出血倾向,但他被诊断为凝血因子 XII 缺乏,术中及术后均无出血并发症。